All stock lists
Unlock the score
Cooper Companies, Inc. (NASDAQ:COO)
US · Delayed Price · Currency is USD
Also listed: 0I3I.LHealthcare · Medical - Instruments & Supplies
61.14-0.07 (-0.11%)
Market cap
$11.6B
Insider Score
Health Score
Analyst consensus
Listed since
Jan 21, 1983
Website
Insider Score
/ 100
COO Insider Score
COOPER COMPANIES, INC. has a live Insider Score.
Scored on 5 qualifying trades from 3 insiders in the last 90 days.
COO analyst forecast
COO analyst consensus
Hold11 ratings
Buy 3 Hold 8 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
COO 12-month price target
$67.60+10.6% upsideaverage of 5 firms
$75.00High
$59.00Low
Best analysts covering COO
- Baird82%success rate · 11 calls
- Stifel71%success rate · 14 calls
- Mizuho67%success rate · 6 calls
- Piper Sandler64%success rate · 11 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
COO analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Needham | Buy | — | — | Reiterated | 2026-09-15 |
| Mizuho | Outperform | $75.00 | +35.8% | Reiterated | 2026-09-11 | |
| — | B of A Securities | Neutral | — | — | Downgraded | 2026-09-10 |
| — | Baird | Neutral | — | — | Downgraded | 2026-09-10 |
| Needham | Buy | $73.00 | +15.0% | Reiterated | 2026-09-10 | |
| — | William Blair | Market Perform | — | — | Downgraded | 2026-09-10 |
| — | UBS | Neutral | — | — | Reiterated | 2026-09-10 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-09-10 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-09-10 |
| Piper Sandler | Neutral | $59.00 | -7.1% | Downgraded | 2026-09-10 | |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-09-10 |
| — | Stifel | Buy | — | — | Reiterated | 2026-09-10 |
| Stifel Nicolaus | — | $70.00 | +10.3% | — | 2026-09-10 | |
| Robert W. Baird | — | $61.00 | -3.9% | — | 2026-09-10 | |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-08-13 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-07-08 |
| — | BNP Paribas | Outperform | — | — | Reiterated | 2026-06-08 |
| — | Needham | Buy | — | — | Reiterated | 2026-06-05 |
| — | Baird | Outperform | — | — | Reiterated | 2026-06-05 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-06-05 |
| — | Stifel | Buy | — | — | Reiterated | 2026-06-05 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-06-05 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-06-04 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-06-01 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-05-28 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-03-06 |
| — | Needham | Buy | — | — | Reiterated | 2026-03-06 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-03-06 |
| — | Needham | Buy | — | — | Reiterated | 2026-02-03 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-01-26 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-12-08 |
| — | Citigroup | Neutral | — | — | Reiterated | 2025-12-08 |
| — | Goldman Sachs | Sell | — | — | Reiterated | 2025-12-08 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-12-05 |
| — | Mizuho | Outperform | — | — | Reiterated | 2025-12-05 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-12-05 |
| — | Stifel | Buy | — | — | Reiterated | 2025-12-05 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-12-05 |
| — | Needham | Buy | — | — | Reiterated | 2025-12-05 |
| — | Baird | Outperform | — | — | Reiterated | 2025-12-05 |
| — | Wells Fargo | Equal Weight | — | — | Downgraded | 2025-11-13 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-08-28 |
| — | Citigroup | Neutral | — | — | Downgraded | 2025-08-28 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-08-28 |
| — | Needham | Buy | — | — | Reiterated | 2025-08-28 |
| — | Stifel | Buy | — | — | Reiterated | 2025-08-28 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-08-28 |
| — | Baird | Outperform | — | — | Reiterated | 2025-08-28 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-08-28 |
| — | Mizuho | Outperform | — | — | Reiterated | 2025-07-16 |
| — | Needham | Buy | — | — | Upgraded | 2025-06-17 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-05-30 |
| — | Needham | Hold | — | — | Reiterated | 2025-05-30 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2025-05-30 |
| — | Baird | Outperform | — | — | Reiterated | 2025-05-30 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-05-30 |
| — | Needham | Hold | — | — | Reiterated | 2025-05-22 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-03-07 |
| — | Needham | Hold | — | — | Reiterated | 2025-03-07 |
| — | Baird | Outperform | — | — | Reiterated | 2025-03-07 |
COO earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-05 | 1.03 | 1.10 | $1.02B | $1.02B |
| 2026-06-04 | 1.10 | 1.21 | $1.05B | $1.08B |
| 2026-09-09 | 1.12 | 1.15 | $1.10B | $1.07B |
| 2026-12-03 | 1.07 | 0.00 | $1.07B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.